Interpretive Statement on Cannabinoid Additives
Consistent with RCW 34.05.230, WSLCB has published an interpretive statement to clarify WAC 314-55-109 concerning cannabinoid additives.
One of the key findings of the 2019 Hillard Heintz report was that WSLCB licensees expressed concerns about inconsistent interpretation of law and regulation applying to their businesses.
Interpretive statements do not have the force and effect of law. They are explanatory documents intended to convey the Washington State Liquor and Cannabis Board’s interpretation of law and regulation as it exists at the time the statement is issued. Current interpretive statements are advisory only.
WLSCB Interpretive Statement #IS21-01 was filed with the Washington State Code Reviser on January 26, 2021 as WSR 21-04-030. The interpretive statement is intended to clarify and confirm current rule, WAC 314-55-109, concerning cannabinoid additives – requirements, restrictions, and quality assurance testing, including the ways that cannabidiol (CBD) 1 product obtained from a source not licensed under chapter 314-55 WAC may be sold in licensed retail locations.
Additional information can be found on the WSLCB Interpretive Statements webpage.
|WSLCB publishes interpretive statement on cannabinoid additives|